35 research outputs found
Baseline predictors of resistant hypertension in the Anglo- Scandinavian Cardiac Outcome Trial (ASCOT): a risk score to identify those at high-risk
a , on behalf of the ASCOT investigators Background Resistant hypertension is a well recognized clinical entity, which has been inadequately researched to date. Methods A multivariable Cox model was developed to identify baseline predictors of developing resistant hypertension among 3666 previously untreated AngloScandinavian Cardiac Outcome Trial (ASCOT) patients and construct a risk score to identify those at high risk. Secondary analyses included evaluations among all 19 257 randomized patients. Results One-third (1258) of previously untreated, and onehalf Conclusion Baseline SBP and choice of subsequent antihypertensive therapy were the two most important determinants of resistant hypertension in the ASCOT population. Individuals at high risk of developing resistant hypertension can be easily identified using an integerbased risk score
The second systolic radial blood pressure peak predicts cardiovascular risk only in subjects below 50 years of age
Morning hypertension assessed by home or ambulatory monitoring: different aspects of the same phenomenon?
Ambulatory and home blood pressure monitoring in children and adolescents: diagnosis of hypertension and assessment of target-organ damage
Prediction of treatment-induced changes in target-organ damage using changes in clinic, home and ambulatory blood pressure
Long-term reproducibility of home vs. office blood pressure in children and adolescents: the Arsakeion school study
Long-term reproducibility of home vs. office blood pressure in children and adolescents: the Arsakeion school study
This study compared the long-term reproducibility of home blood pressure
(BP) in comparison with office BP in children and adolescents.
Forty-eight subjects (27 boys, mean age 11.3 +/- 3.1 (s.d.) years)
recruited from the Arsakeion school study because of elevated office
and/or home BP were assessed with office (1 visit, mercury
sphygmomanometer) and home BP measurements (3 days, electronic devices)
in two assessments 17 +/- 4.9 months apart (range 10-26 months). Home
and office BP were compared on the basis of the following criteria: (a)
s.d. of mean BP; (b) s.d. of differences; (c) variation coefficient
(CV); (d) concordance correlation coefficient (CCC); (e) test-retest
correlations; (f) correlation with ambulatory BP. (a) The s.d. of mean
home BP was lower than that of office BP in both the initial (home BP
9.1/7.1 mm Hg, systolic/diastolic; office BP 13.1/8.0 mm Hg) and the
second assessment (9.2/6.0 and 14.9/11.5 respectively). (b) The s.d. of
differences was lower for home BP (8.3/6.5 mm Hg, systolic/diastolic)
than for office BP (13.9/10.7 mm Hg). (c) The CV of home BP (5.3/6.6,
systolic/diastolic) was lower than that of office BP (8.2/10.9). (d) The
CCC of home BP (0.54/0.50, systolic/diastolic) was higher than that of
office BP (0.51/0.41). (e) Test-retest correlations were closer for home
BP (r=0.58/0.52, systolic/diastolic) than for office BP (0.51/0.44). (f)
Awake ambulatory BP was more closely associated with home (r=0.77/0.40,
systolic/diastolic) than with office BP (0.65/0.24). These data suggest
that in children and adolescents the long-term reproducibility of home
BP is superior to that of office measurements
